Sartorius Stedim Biotech SA
F:56S1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sartorius Stedim Biotech SA
F:56S1
|
FR |
|
Invibes Advertising NV
PAR:ALINV
|
BE |
|
Y
|
Yungshin Construction & Development Co Ltd
TPEX:5508
|
TW |
|
Scor SE
F:SDRB
|
FR |
|
Educomp Solutions Ltd
NSE:EDUCOMP
|
IN |
|
Battery X Metals Inc
OTC:BATXF
|
CA |
|
PYC Therapeutics Ltd
OTC:PYCXF
|
AU |
|
Northern Minerals Ltd
ASX:NTU
|
AU |
|
F
|
Fair Value REIT-AG
F:FVI
|
DE |
|
H
|
Hankuk Steel Wire Co Ltd
KOSDAQ:025550
|
KR |
|
Symrise AG
F:SY1U
|
DE |
|
A
|
Adventa Bhd
KLSE:ADVENTA
|
MY |
|
E
|
El Capitan Precious Metals Inc
OTC:ECPN
|
US |
|
K
|
Keyang Electric Machinery Co Ltd
KRX:012200
|
KR |
|
Astrotech Corp
NASDAQ:ASTC
|
US |
|
Family Office of America Inc
OTC:FOFA
|
US |
|
Bioretec Oy
F:0TN
|
FI |
|
Cybertrust Japan Co Ltd
F:5U2
|
JP |
|
Guoco Group Ltd
HKEX:53
|
HK |
|
C
|
CD Projekt SA
WSE:CDR
|
PL |
Bankruptcy Probability
Sartorius Stedim Biotech SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Sartorius Stedim Biotech SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FR |
|
Sartorius Stedim Biotech SA
PAR:DIM
|
21.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
249.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Danaher Corp
NYSE:DHR
|
162.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
435.6B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Lonza Group AG
SIX:LONN
|
44.1B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
67.1T KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Agilent Technologies Inc
NYSE:A
|
48.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
46B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Waters Corp
NYSE:WAT
|
44.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Illumina Inc
NASDAQ:ILMN
|
40.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Mettler-toledo International Inc
NYSE:MTD
|
36.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Sartorius Stedim Biotech SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Sartorius Stedim Biotech SA has total debt of 2.1B EUR. This includes both short-term (0 EUR) and long-term (2.1B EUR) debt.
You can find a full breakdown on its Balance Sheet.